Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
The latest announcement is out from Indivior ( (GB:INDV) ).
Indivior PLC has been notified of a change in major holdings involving Two Seas Capital LP, which has adjusted its voting rights in the company. As of December 27, 2024, Two Seas Capital LP holds 9.960998% of voting rights, a slight decrease from its previous position. This adjustment may impact Indivior’s shareholder dynamics and influence, reflecting changes in strategic investments by major stakeholders.
More about Indivior
Indivior PLC is a UK-based pharmaceutical company, primarily focused on developing and marketing addiction treatment medications. It is renowned for its leadership in opioid addiction treatments and holds a prominent position in the global market for addiction therapies.
YTD Price Performance: -18.27%
Average Trading Volume: 444,204
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £1.21B
For detailed information about INDV stock, go to TipRanks’ Stock Analysis page.
